15 ML atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML Injection [Tecentriq Hybreza]
RxNorm concept 2693899, branded drug (sbd). Prescribable name: Tecentriq Hybreza 1875 MG / 30,000 UNT in 15 ML Injection.
- RxCUI
- 2693899
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693899 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Tecentriq Hybreza (atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT) per 15 ML Injection
Related concepts
- atezolizumab-tqjs 125 MG/ML (SCDC, consists of)
- hyaluronidase-tqjs 2000 UNT/ML (SCDC, consists of)
- atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML [Tecentriq Hybreza] (SBDC, consists of)
- Injection (DF, has dose form)
- Tecentriq Hybreza (BN, has ingredient)
- 15 ML atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2693899 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693899 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2693899. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.